Disclosed are compositions and methods for their use that include a combination of hydrolyzed algin, escin, Ruscus aculeatus root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein, and Calendula officinalis flower extract.
대표청구항▼
1. A topical skin composition comprising an effective amount of hydrolyzed algin, escin, Ruscus aculeatus root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein, and Calendula officinalis flower extract, wherein the composition is capable of reducing cytokine produ
1. A topical skin composition comprising an effective amount of hydrolyzed algin, escin, Ruscus aculeatus root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein, and Calendula officinalis flower extract, wherein the composition is capable of reducing cytokine production and reducing oxidative damage in skin cells. 2. The topical skin composition of claim 1, further comprising between 80 to 90% by weight of water. 3. The topical skin composition of claim 2, comprising 0.005 to 0.05% by weight of hydrolyzed algin. 4. The topical skin composition of claim 3, comprising 0.001 to 0.05% by weight of escin, 0.001 to 0.01% by weight of Ruscus aculeatus root extract, 0.001 to 0.01% by weight of ammonium glycyrrhizate, 0.0005 to 0.005% by weight of Centella asiatica extract, 0.0003 to 0.003% by weight of hydrolyzed yeast protein, and 0.0003 to 0.003% by weight of Calendula officinalis flower extract. 5. The topical skin composition of claim 3, further comprising Opuntia tuna fruit extract. 6. The topical skin composition of claim 1, wherein the composition further includes: butylene glycol;glycerin;propylene glycol;diazolidinyl urea;PPG-5-ceteth-20;methylparaben;sodium citrate;disodium EDTA;buteth-3;propylparaben;citric acid;sodium benzotriazolyl butylphenol sulfonate; andpanthenol. 7. The topical skin composition of claim 6, wherein the composition includes: 5 to 7% by weight of butylene glycol;3 to 5% by weight of glycerin;0.3 to 0.7% by weight of propylene glycol;0.1 to 0.5% by weight of diazolidinyl urea;0.1 to 0.5% by weight of PPG-5-ceteth-20;0.1 to 0.5% by weight of methylparaben;0.05 to 0.1% by weight of sodium citrate;0.03 to 0.07% by weight of disodium EDTA;0.03 to 0.07% by weight of buteth-3;0.01 to 0.05% by weight of propylparaben;0.01 to 0.05% by weight of citric acid;0.01 to 0.05% by weight of sodium benzotriazolyl butylphenol sulfonate; and0.01 to 0.05% by weight of panthenol. 8. The topical skin composition of claim 1, wherein the composition further includes: glycerin;pentylene glycol;glycereth-26;propylene glycol;triethanolamine;acrylates/C10-30 alkyl acrylate crosspolymer;diazolidinyl urea;hydroxyethylcellulose;sodium polyacrylate;methylparaben;disodium EDTA;butylene glycol;phenoxyethanol;caprylyl glycol;propylparaben; andpanthenol. 9. The topical skin composition of claim 8, wherein the composition includes: 3 to 7% by weight of glycerin;3 to 7% by weight of pentylene glycol;1 to 3% by weight of glycereth-26;0.3 to 0.7% by weight of propylene glycol;0.3 to 0.7% by weight of triethanolamine;0.1 to 0.5% by weight of acrylates/C10-30 alkyl acrylate crosspolymer;0.1 to 0.5% by weight of diazolidinyl urea;0.1 to 0.5% by weight of hydroxyethylcellulose;0.1 to 0.5% by weight of sodium polyacrylate;0.1 to 0.5% by weight of methylparaben;0.05 to 0.5% by weight of disodium EDTA;0.05 to 0.1% by weight of butylene glycol;0.03 to 0.07% by weight of phenoxyethanol;0.03 to 0.07% by weight of caprylyl glycol;0.01 to 0.05% by weight of propylparaben; and0.01 to 0.05% by weight of panthenol. 10. The topical skin composition of claim 1, wherein the composition further includes: pentylene glycol;polysilicone-11;hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer;dimethicone;squalane;glyceryl undecylenate;silica;butylene glycol;triethanolamine;polysorbate 60;acrylates/C10-30 alkyl acrylate crosspolymer;hydroxypropyl cyclodextrin;sorbitan isostearate;panthenol; andglycerin. 11. The topical skin composition of claim 10, wherein the composition includes: 3 to 7% by weight of pentylene glycol;1 to 5% by weight of polysilicone-11;1 to 5% by weight of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer;1 to 3% by weight of dimethicone;1 to 3% by weight of squalane;0.5 to 2% by weight of glyceryl undecylenate;0.3 to 0.7% by weight of silica;0.1 to 0.5% by weight of butylene glycol;0.1 to 0.5% by weight of triethanolamine;0.1 to 0.5% by weight of polysorbate 60;0.1 to 0.5% by weight of acrylates/C10-30 alkyl acrylate crosspolymer;0.05 to 0.1% by weight of hydroxypropyl cyclodextrin;0.05 to 0.1% by weight of sorbitan isostearate;0.03 to 0.07% by weight of panthenol; and0.03 to 0.07% by weight of glycerin. 12. The topical skin composition of claim 11, wherein the composition further includes benzyl alcohol. 13. The topical skin composition of claim 12, wherein the composition includes 0.1 to 1% by weight of benzyl alcohol. 14. The topical skin composition of claim 1, wherein the composition further includes: glycerin;pentylene glycol;glycereth-26;benzyl alcohol;triethanolamine;acrylates/C10-30 alkyl acrylate crosspolymer;hydroxyethylcellulose;sodium polyacrylate;disodium EDTA;hydroxypropyl cyclodextrin;butylene glycol;phenoxyethanol;caprylyl glycol; andpanthenol. 15. The topical skin composition of claim 14, wherein the composition includes: 3 to 7% by weight of glycerin;2 to 5% by weight of pentylene glycol;1 to 3% by weight of glycereth-26;0.3 to 1.5% by weight of benzyl alcohol;0.1 to 1.5% by weight of triethanolamine;0.1 to 0.7% by weight of acrylates/C10-30 alkyl acrylate crosspolymer;0.01 to 1.0% by weight of hydroxyethylcellulose;0.01 to 1.0% by weight of sodium polyacrylate;0.01 to 1.0% by weight of disodium EDTA;0.01 to 1.0% by weight of hydroxypropyl cyclodextrin;0.01 to 1.0% by weight of butylene glycol;0.01 to 1.0% by weight of phenoxyethanol;0.01 to 0.1% by weight of caprylyl glycol; and0.005 to 0.1% by weight of panthenol. 16. A method of reducing pro-inflammatory cytokine production in skin cells and protecting skin from oxidative damage from free radicals comprising topically applying the composition of claim 1 to skin in need thereof, wherein said composition reduces pro-inflammatory cytokine production in skin cells and protects skin from oxidative damage from free radicals. 17. The method of claim 16, wherein the pro-inflammatory cytokine is TNF-α, IL-6, IL-8, IL-10, IL-12 p40, or GM-CSF, or any combination or all thereof. 18. The method of claim 17, wherein the composition is applied to erythemic, sensitive, or inflamed skin. 19. The method of claim 17, wherein the composition is applied to dry, flaky, or itchy skin. 20. A method of reducing CGRP production in skin cells and protecting skin from oxidative damage from free radicals comprising topically applying the composition of claim 1 to skin in need thereof, wherein said composition reduces CGRP production in skin cells and protects skin from oxidative damage from free radicals. 21. The method of claim 20, wherein the composition is applied to erythemic, sensitive, or inflamed skin. 22. The method of claim 20, wherein the composition is applied to dry, flaky, or itchy skin.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.